Testing effectiveness (Phase 2)Active Not RecruitingNCT07197268
What this trial is testing
Personalized Antisense Oligonucleotide Therapy for A Single Participant With ASXL3 Gene Mutation
Who this might be right for
Bainbridge-Ropers Syndrome
n-Lorem Foundation 1